Acasti Pharma Inc.
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada. Show More...
-
Website http://www.acastipharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 3.37 USD
-
Last Updated 25-10-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2009-02 2010-02 2011-02 2012-02 2013-02 2014-02 2015-02 2016-02 2018-03 2019-03 TTM Earnings Per Share CAD -0.69 -0.59 -1.0 -0.9 -1.38 -0.16 -0.59 -1.23 -0.95 -0.87 Dividends CAD Payout Ratio % * Shares Mil 2.0 5.0 7.0 7.0 8.0 11.0 11.0 17.0 54.0 82.0 Book Value Per Share * USD 0.46 0.29 -0.05 Free Cash Flow Per Share * USD -0.25 -0.49 Return on Assets % -169.72 -111.37 -68.23 -49.41 -40.18 -4.0 -19.22 -88.83 -144.38 -147.42 Financial Leverage (Average) 1.08 1.25 1.37 1.12 1.05 2.79 3.47 Return on Equity % -102.6 -56.98 -54.0 -4.98 -20.9 -143.71 -464.85 -594.28 Return on Invested Capital % -103.14 -57.35 -54.15 -5.23 -21.14 -128.76 -400.28 -513.75 Interest Coverage -724.39 -406.57 -57.75 -140.28 -211.38 Current Ratio 0.19 3.48 7.03 2.4 22.05 12.11 9.93 1.42 2.04 2.07 Quick Ratio 0.19 3.46 6.52 2.3 21.23 11.86 9.53 1.34 1.97 1.91 Debt/Equity 0.2